Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden
· Delayed Price · Currency is SEK 12.16
+0.06 (0.50%)
At close: Apr 28, 2026
Cinclus Pharma Holding AB Revenue
In the year 2025, Cinclus Pharma Holding AB had annual revenue of 57.47M SEK with 1,154.80% growth. Cinclus Pharma Holding AB had revenue of 13.63M in the quarter ending December 31, 2025, with 197.62% growth.
Revenue
57.47M
Revenue Growth
+1,154.80%
P/S Ratio
9.85
Revenue / Employee
2.74M
Employees
21
Market Cap
565.90M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Moberg Pharma AB | 13.54M |
| Nanexa AB | 55.94M |
| Enzymatica AB | 53.90M |
| Orexo AB | 26.00M |
| Dicot Pharma AB | 200.00K |
| Klaria Pharma Holding AB (publ.) | 8.99M |
| EQL Pharma AB | 425.75M |
| Cereno Scientific AB | 44.27M |
Cinclus Pharma Holding AB News
- 2 months ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - Cinclus Pharma Holding AB Transcript: KOL Event - Transcripts
- 5 months ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q3 2025 - Transcripts
- 6 months ago - Cinclus Pharma Holding AB Transcript: Stifel 2025 Healthcare Conference - Transcripts
- 9 months ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - Cinclus Pharma Holding AB Transcript: Investor Update - Transcripts
- 1 year ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q4 2024 - Transcripts